Testing effectiveness (Phase 2)Study completedNCT02818920What this trial is testingNeoadjuvant PembrolizumabWho this might be right forNon-small Cell Lung Carcinoma Neal Ready MD PhD 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)Study completedNCT00193310What this trial is testingPreoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung CancerWho this might be right forLung Cancer SCRI Development Innovations, LLC 250
Testing effectiveness (Phase 2)Study completedNCT01134250What this trial is testingCombination Therapy of F16IL2 and Paclitaxel in Solid Tumour PatientsWho this might be right forSolid TumorBreast CancerMetastatic Melanoma+1 more Philogen S.p.A. 48
Testing effectiveness (Phase 2)Looking for participantsNCT06589778What this trial is testingSHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Shanghai Hengrui Pharmaceutical Co., Ltd. 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472478What this trial is testingPhase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)Who this might be right forLung Cancer (NSCLC)KRAS G12C Lung Cancer Guangdong Provincial People's Hospital 32
Testing effectiveness (Phase 2)Study completedNCT01982955What this trial is testingTepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)Who this might be right forNon-small Cell Lung Cancer Merck KGaA, Darmstadt, Germany 88
Testing effectiveness (Phase 2)Study completedNCT00792701What this trial is testingS0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerWho this might be right forLung Cancer SWOG Cancer Research Network 85
Early research (Phase 1)Ended earlyNCT00856427What this trial is testingImplantation of Markers for the Radiotherapy of Lung Cancer PatientsWho this might be right forLung Cancer Virginia Commonwealth University 6
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Ended earlyNCT02920450What this trial is testingStudy of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)Who this might be right forNon-Small Cell Lung Cancer University of Florida 3
Not applicableStudy completedNCT01772225What this trial is testingNSCLC Burden of Illness StudyWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 1
Early research (Phase 1)WithdrawnNCT02451865What this trial is testingBinimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01207726What this trial is testingAzacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By SurgeryWho this might be right forStage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)WithdrawnNCT05879484What this trial is testingStudy of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERASWho this might be right forSinonasal CancerSquamous Non-small Cell Lung CancerLung Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT04611776What this trial is testingA Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small Cell Lung Hoffmann-La Roche
Testing effectiveness (Phase 2)WithdrawnNCT02522910What this trial is testingAn Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forNSCLC (Non-Small Cell Lung Cancer) Yonsei University
Testing effectiveness (Phase 2)Study completedNCT04742959What this trial is testingStudy of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCholangiocarcinomaHER2-negative Breast Cancer+8 more TransThera Sciences (Nanjing), Inc. 203
Testing effectiveness (Phase 2)Looking for participantsNCT07590531What this trial is testingAMT-116 in Combination With AK112 in Patients With Lung CancerWho this might be right forAdvanced Non-small Cell Lung Cancer (NSCLC) Multitude Therapeutics Inc. 118
Testing effectiveness (Phase 2)Study completedNCT00034541What this trial is testingStudy of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 32